NCATS E-Newsletter: May 2016

Read the latest news and updates from NCATS.

Is this email not displaying correctly?
View it in your browser.


Volume 05 • Issue 05 • May 26, 2016

Director's Message

	NCATS accelerates translational science through initiatives that push the boundaries of biomedical research to revolutionize the way we study diseases and discover treatments. I am very excited about a new such signature initiative: NCATS’ Biomedical Data Translator program...

Connect with NCATS

	Facebook
	Twitter
	YouTube
	Subscribe

Top Story

Ketamine Metabolite May Fight Depression

NCATS scientists were part of a team that helped identify a chemical byproduct — a metabolite — that is created as the body breaks down ketamine. This metabolite reversed depression-like behaviors in mice without triggering the dissociative and addictive side effects associated with ketamine. Read more >

CTSA Program Supports Streamlined Clinical Trial Recruitment

Researchers at the University of New Mexico Clinical and Translational Science Center recently established the Participant Recruitment Service. Supported through NCATS’ Clinical and Translational Science Awards Program, the goal is to streamline and improve recruitment rates for clinical trials while maintaining patient privacy. Read more >

NCATS Funding Opportunity for Biomedical Data Translator

NCATS launched its Biomedical Data Translator program to accelerate biomedical translation by developing a “data translator” for researchers. Through this program, NCATS will integrate multiple types of existing data sources and reveal potential relationships across the spectrum of data types. Proposals for the architecture and technical feasibility of the translator are due June 1, 2016. Read more >

Spheryx, Inc., President/CEO Talks SBIR-Supported Tech

A recent CEOCFO Magazine article features Spheryx, Inc., president and CEO Laura A. Philips, Ph.D., M.B.A., discussing the company’s innovative approach to analyzing particles suspended in fluids. Supported in part by an NCATS Small Business Innovation Research grant, Spheryx provides technology that enables the pharmaceutical industry to study product stability. Read more >

Meet More of NCATS’ Staff

Redonna K. Chandler, Ph.D., is the deputy director of the NCATS Division of Clinical Innovation. Sury Vepa, Ph.D., J.D., is the senior licensing and patenting manager in the Office of Policy, Communications and Strategic Alliances. Learn more about these and other NCATS staff members via NCATS Staff Profiles >

Announcements

JUNE

Deadline for NIH researchers to submit Pfizer Centers for Therapeutic Innovation (CTI) pre-proposals to their Technology Transfer Offices.

JUNE

Next deadline for NIH Technology Transfer Offices to submit proposals to the Pfizer CTI program.

Research Opportunities and Announcements Highlights

NCATS in the News

like us on Facebook | follow us on Twitter | forward to a friend | watch us on YouTube

National Center for Advancing Translational Sciences

National Institutes of Health

6701 Democracy Boulevard, 9th Floor

Bethesda, MD 20892

For language access assistance, contact
the NCATS Public Information Officer.

Add us to your address book | Unsubscribe